含脂附件肿块MRI:实性组织体积与脂肪分布辅助O-RADS评分
这项单中心回顾性研究纳入188例含脂附件肿块患者,评估整体大小、实性组织大小及脂肪分布与恶性的关联。非Rokitansky结节实性组织大小鉴别良恶性AUC最高(R1 0.83,R2 0.86),取阈值≥1.2cm或≥1.0cm时敏感度0.72-0.76、特异度0.93-0.95。作者认为这些指标可简单实用地改进O-RADS MRI评分。
要点
- 含脂附件肿块需测量非Rokitansky结节实性组织大小,其鉴别良恶性效能优于整体大小。
- 非Rokitansky结节实性组织≥1.2cm(R1)或≥1.0cm(R2)时特异度达0.93-0.95。
- 未成熟畸胎瘤中85.7%表现为散在脂肪分布,需警惕。
关键影像表现/征象
- 恶性组整体大小、任何实性组织大小、非Rokitansky结节实性组织大小均大于良性组(p<0.01)。
- 脂肪分布在良恶性组间差异显著(p<0.01)。
- 未成熟畸胎瘤中85.7%表现为散在脂肪分布。
诊断标准与关键数值
- 非Rokitansky结节实性组织大小AUC:R1 0.83,R2 0.86;整体大小AUC:R1 0.78,R2 0.81;任何实性组织大小AUC:R1 0.79,R2 0.81,差异无统计学意义(p=0.48-0.93)。
- 非Rokitansky结节实性组织阈值≥1.2cm(R1)时敏感度0.72、特异度0.93;≥1.0cm(R2)时敏感度0.76、特异度0.95。
临床应用与阅片要点
- 阅片时应测量非Rokitansky结节的实性组织大小,而非仅测整体大小或任何实性组织。
- 注意脂肪分布模式,散在脂肪见于多数未成熟畸胎瘤。
- 可将非Rokitansky结节实性组织大小和脂肪分布纳入O-RADS MRI评分以细化风险分层。
局限性
- 回顾性单中心设计。
- 恶性病例数较少(25例)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: To explore ways to improve O-RADS MRI scoring for fat-containing adnexal masses, by investigating methods for quantifying solid tissue volume and fat distribution and evaluating their associations with malignancy.
METHODS: This retrospective, single-center study included patients with fat-containing adnexal masses on MRI during 2008-2021. Two radiologists independently reviewed overall size (Sizeoverall), size of any solid tissue (Sizeanysolid), size of solid tissue that was not Rokitansky nodule (Sizenon-Rokitansky), and fat distribution. Wilcoxon test, Fisher-exact test, and ROC curve analysis were performed. Reference standard was pathology or follow-up > 24 months.
RESULTS: 188 women (median age 35 years) with 163 benign and 25 malignant lesions were included. Sizeoverall (R1, 9.9 cm vs 5.9 cm; R2, 12.4 cm vs 6.0 cm), Sizeanysolid (R1, 5.1 cm vs 1.2 cm; R2, 3.2 cm vs 0.0 cm), Sizenon-Rokitansky (R1, 5.1 cm vs 0.0 cm; R2, 3.1 cm vs 0.0 cm), and fat distribution differed significantly between malignant and benign lesions (p < 0.01). Area under ROC curve was greatest using Sizenon-Rokitansky (R1, 0.83; R2, 0.86) vs Sizeoverall (R1, 0.78; R2, 0.81) or Sizeanysolid (R1, 0.79; R2, 0.81), though differences were non-significant (p = 0.48-0.93). Cutoffs for Sizenon-Rokitansky (R1, ≥ 1.2 cm; R2, ≥ 1.0 cm) yielded sensitivity and specificity of 0.72 and 0.93 (R1) and 0.76 and 0.95 (R2). Among immature teratomas, 85.7% displayed scattered fat.
CONCLUSION: Overall size, size of (any or non-Rokitansky-nodule) solid tissue, and fat distribution differed between benign and malignant fat-containing adnexal masses. Incorporating these would constitute simple and practical approaches to refining O-RADS MRI scoring.
引用
- Cheng, Causa Andrieu, Kim, et al. Fat-containing adnexal masses on MRI: solid tissue volume and fat distribution as a guide for O-RADS Score assignment. Abdom Radiol (NY). 2022. PMID: 36173552. doi:10.1007/s00261-022-03688-x
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。